Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Allergy & Immunology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Experts Clear the Air on the Burden of CRSwNP
December 2025
Chronic rhinosinusitis is a chronic inflammatory condition of the paranasal sinuses and nasal cavities, affecting an estimated 2–12% of the…
Read more
6
Mins
20 Jul 2023
Putting Guidelines into Practice: Supporting Young People with Hereditary Angioedema to Live Attack-Free
The availability of specific licensed medicines to treat acute HAE attacks and prophylactic options to prevent future episodes is changing the way people with HAE are treated, and is giving them hope for a future free from debilitating HAE attacks.
10
Mins
20 Jul 2023
Editor’s Pick: Drug-Induced Thrombocytopenic Purpura
In the present systematic review and meta-analysis, the authors analysed case reports of drug-induced thrombocytopenia/drug-induced…
3
Mins
17 Jul 2023
The Role of Co-Factors in Mast Cell Activation
Degranulation of activated mast cells affects many conditions and can modulate physiological and pathological responses…
8
Mins
5 Jul 2023
Paediatric Post-SARS-CoV-2 Multisystemic Syndrome
A novel characterised hyper inflammatory condition has been observed in children who have recently had severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections during the COVID-19 pandemic.
3
Mins
29 Jun 2023
The Danger of Disappearing Allergen Skin Test Substances
Allergic diseases affect approximately one-quarter to one-half of the average population under 50 years of age in Central Europe…
11
Mins
12 Apr 2023
IL-17 and -23 Inhibitors for the Treatment of Psoriasis
Psoriasis is a chronic inflammatory skin disorder affecting approximately 60 million people worldwide. The condition presents with rapid hyperproliferation and dysregulated differentiation of epidermal keratinocytes, manifesting clinically as salmon pink plaques with overlying silvery-white scale.
3
Mins
21 Mar 2023
Interview: David Stukus
David Stukus – Professor of Clinical Pediatrics, Division of Allergy and Immunology; Director, Food Allergy Treatment Center, Nationwide Children’s Hospital and The Ohio State University College of Medicine, Columbus, Ohio, USA
10
Mins
19 Jan 2023
Can Human Milk Oligosaccharides Modulate the Allergic Response and Improve the Management of Cow’s Milk Protein Allergy?
Human milk oligosaccharides (HMOs) support the development of the infant microbiome and have immune benefits in the management of cow’s milk protein allergy (CMPA).
Loading posts...
« Previous
1
…
3
4
5
6
7
…
16
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View